Correlation Between Syndax Pharmaceuticals and Day One
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Day One.
Diversification Opportunities for Syndax Pharmaceuticals and Day One
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Syndax and Day is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Day One go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Day One
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to under-perform the Day One. In addition to that, Syndax Pharmaceuticals is 1.67 times more volatile than Day One Biopharmaceuticals. It trades about -0.04 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest 1,389 in Day One Biopharmaceuticals on September 4, 2024 and sell it today you would lose (5.00) from holding Day One Biopharmaceuticals or give up 0.36% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Syndax Pharmaceuticals vs. Day One Biopharmaceuticals
Performance |
Timeline |
Syndax Pharmaceuticals |
Day One Biopharmaceu |
Syndax Pharmaceuticals and Day One Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Syndax Pharmaceuticals and Day One
The main advantage of trading using opposite Syndax Pharmaceuticals and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |